HEADER HYDROLASE/INHIBITOR 04-OCT-18 6MO5 TITLE CO-CRYSTAL STRUCTURE OF P. AERUGINOSA LPXC-50228 COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: UDP-3-O-ACYL-N-ACETYLGLUCOSAMINE DEACETYLASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: UDP-3-O-ACYL-GLCNAC DEACETYLASE,UDP-3-O-[R-3- COMPND 5 HYDROXYMYRISTOYL]-N-ACETYLGLUCOSAMINE DEACETYLASE; COMPND 6 EC: 3.5.1.108; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PSEUDOMONAS AERUGINOSA (STRAIN ATCC 15692 / DSM SOURCE 3 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1); SOURCE 4 ORGANISM_TAXID: 208964; SOURCE 5 STRAIN: ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 SOURCE 6 / 1C / PRS 101 / PAO1; SOURCE 7 GENE: LPXC, ENVA, PA4406; SOURCE 8 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 9 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS HYDROLASE LPXC PSEUDOMONAS AERUGINOSA, HYDROLASE, HYDROLASE-INHIBITOR KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR A.J.STEIN,M.C.HOLT,Z.ASSAR,F.COHEN,L.ANDREWS,R.CIRZ REVDAT 4 13-MAR-24 6MO5 1 REMARK REVDAT 3 04-SEP-19 6MO5 1 JRNL REVDAT 2 24-JUL-19 6MO5 1 JRNL REVDAT 1 17-JUL-19 6MO5 0 JRNL AUTH F.COHEN,J.B.AGGEN,L.D.ANDREWS,Z.ASSAR,J.BOGGS,T.CHOI, JRNL AUTH 2 P.DOZZO,A.N.EASTERDAY,C.M.HAGLUND,D.J.HILDEBRANDT,M.C.HOLT, JRNL AUTH 3 K.JOLY,A.JUBB,Z.KAMAL,T.R.KANE,A.W.KONRADI,K.M.KRAUSE, JRNL AUTH 4 M.S.LINSELL,T.D.MACHAJEWSKI,O.MIROSHNIKOVA,H.E.MOSER, JRNL AUTH 5 V.NIETO,T.PHAN,C.PLATO,A.W.SERIO,J.SEROOGY,A.SHAKHMIN, JRNL AUTH 6 A.J.STEIN,A.D.SUN,S.SVIRIDOV,Z.WANG,K.WLASICHUK,W.YANG, JRNL AUTH 7 X.ZHOU,H.ZHU,R.T.CIRZ JRNL TITL OPTIMIZATION OF LPXC INHIBITORS FOR ANTIBACTERIAL ACTIVITY JRNL TITL 2 AND CARDIOVASCULAR SAFETY. JRNL REF CHEMMEDCHEM V. 14 1560 2019 JRNL REFN ESSN 1860-7187 JRNL PMID 31283109 JRNL DOI 10.1002/CMDC.201900287 REMARK 2 REMARK 2 RESOLUTION. 1.85 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC (1.12_2829: ???) REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.85 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 33.24 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.370 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 25662 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.180 REMARK 3 R VALUE (WORKING SET) : 0.177 REMARK 3 FREE R VALUE : 0.219 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1308 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 33.2400 - 3.8487 1.00 2757 171 0.1464 0.1560 REMARK 3 2 3.8487 - 3.0555 1.00 2730 129 0.1679 0.2286 REMARK 3 3 3.0555 - 2.6695 1.00 2725 145 0.1883 0.2280 REMARK 3 4 2.6695 - 2.4255 1.00 2715 135 0.2042 0.2854 REMARK 3 5 2.4255 - 2.2517 1.00 2674 162 0.1903 0.2489 REMARK 3 6 2.2517 - 2.1190 1.00 2684 159 0.1893 0.2501 REMARK 3 7 2.1190 - 2.0128 1.00 2682 145 0.1819 0.2284 REMARK 3 8 2.0128 - 1.9252 1.00 2734 126 0.2053 0.2505 REMARK 3 9 1.9252 - 1.8511 0.98 2653 136 0.2193 0.2780 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.190 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 21.490 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 2482 REMARK 3 ANGLE : 0.860 3369 REMARK 3 CHIRALITY : 0.063 385 REMARK 3 PLANARITY : 0.004 436 REMARK 3 DIHEDRAL : 20.081 1498 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6MO5 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-OCT-18. REMARK 100 THE DEPOSITION ID IS D_1000237315. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-AUG-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 21-ID-F REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 24354 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.850 REMARK 200 RESOLUTION RANGE LOW (A) : 33.240 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 2.000 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.8200 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.85 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.89 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.76 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.27 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 50 MM MGCL2, 30% PEG MME 5000 AND 0.2 REMARK 280 M KSCN, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 33.24300 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 167 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE2 GLU A 287 O HOH A 401 1.91 REMARK 500 OE2 GLU A 198 O HOH A 402 2.04 REMARK 500 O HOH A 488 O HOH A 530 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A -2 173.54 174.74 REMARK 500 THR A 61 -101.54 -61.86 REMARK 500 MET A 103 -127.75 62.48 REMARK 500 ALA A 124 145.00 -171.05 REMARK 500 SER A 178 -56.99 -129.04 REMARK 500 ASP A 218 -158.89 -93.89 REMARK 500 MET A 297 159.62 -49.52 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 302 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 241 OD1 REMARK 620 2 ASP A 241 OD2 59.4 REMARK 620 3 JWP A 301 O22 155.8 96.6 REMARK 620 4 JWP A 301 O24 98.3 86.7 75.4 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue JWP A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MG A 302 DBREF 6MO5 A 2 299 UNP P47205 LPXC_PSEAE 2 299 SEQADV 6MO5 HIS A -4 UNP P47205 EXPRESSION TAG SEQADV 6MO5 HIS A -3 UNP P47205 EXPRESSION TAG SEQADV 6MO5 HIS A -2 UNP P47205 EXPRESSION TAG SEQADV 6MO5 HIS A -1 UNP P47205 EXPRESSION TAG SEQADV 6MO5 ALA A 0 UNP P47205 EXPRESSION TAG SEQADV 6MO5 THR A 1 UNP P47205 EXPRESSION TAG SEQADV 6MO5 VAL A 129 UNP P47205 ILE 129 CONFLICT SEQRES 1 A 304 HIS HIS HIS HIS ALA THR ILE LYS GLN ARG THR LEU LYS SEQRES 2 A 304 ASN ILE ILE ARG ALA THR GLY VAL GLY LEU HIS SER GLY SEQRES 3 A 304 GLU LYS VAL TYR LEU THR LEU LYS PRO ALA PRO VAL ASP SEQRES 4 A 304 THR GLY ILE VAL PHE CYS ARG THR ASP LEU ASP PRO VAL SEQRES 5 A 304 VAL GLU ILE PRO ALA ARG ALA GLU ASN VAL GLY GLU THR SEQRES 6 A 304 THR MET SER THR THR LEU VAL LYS GLY ASP VAL LYS VAL SEQRES 7 A 304 ASP THR VAL GLU HIS LEU LEU SER ALA MET ALA GLY LEU SEQRES 8 A 304 GLY ILE ASP ASN ALA TYR VAL GLU LEU SER ALA SER GLU SEQRES 9 A 304 VAL PRO ILE MET ASP GLY SER ALA GLY PRO PHE VAL PHE SEQRES 10 A 304 LEU ILE GLN SER ALA GLY LEU GLN GLU GLN GLU ALA ALA SEQRES 11 A 304 LYS LYS PHE VAL ARG ILE LYS ARG GLU VAL SER VAL GLU SEQRES 12 A 304 GLU GLY ASP LYS ARG ALA VAL PHE VAL PRO PHE ASP GLY SEQRES 13 A 304 PHE LYS VAL SER PHE GLU ILE ASP PHE ASP HIS PRO VAL SEQRES 14 A 304 PHE ARG GLY ARG THR GLN GLN ALA SER VAL ASP PHE SER SEQRES 15 A 304 SER THR SER PHE VAL LYS GLU VAL SER ARG ALA ARG THR SEQRES 16 A 304 PHE GLY PHE MET ARG ASP ILE GLU TYR LEU ARG SER GLN SEQRES 17 A 304 ASN LEU ALA LEU GLY GLY SER VAL GLU ASN ALA ILE VAL SEQRES 18 A 304 VAL ASP GLU ASN ARG VAL LEU ASN GLU ASP GLY LEU ARG SEQRES 19 A 304 TYR GLU ASP GLU PHE VAL LYS HIS LYS ILE LEU ASP ALA SEQRES 20 A 304 ILE GLY ASP LEU TYR LEU LEU GLY ASN SER LEU ILE GLY SEQRES 21 A 304 GLU PHE ARG GLY PHE LYS SER GLY HIS ALA LEU ASN ASN SEQRES 22 A 304 GLN LEU LEU ARG THR LEU ILE ALA ASP LYS ASP ALA TRP SEQRES 23 A 304 GLU VAL VAL THR PHE GLU ASP ALA ARG THR ALA PRO ILE SEQRES 24 A 304 SER TYR MET ARG PRO HET JWP A 301 56 HET MG A 302 1 HETNAM JWP N-[(2S)-1-(HYDROXYAMINO)-3-METHYL-3-{[(OXETAN-3-YL) HETNAM 2 JWP METHYL]SULFONYL}-1-OXOBUTAN-2-YL]-4-(6-HYDROXYHEXA-1, HETNAM 3 JWP 3-DIYN-1-YL)BENZAMIDE HETNAM MG MAGNESIUM ION FORMUL 2 JWP C22 H26 N2 O7 S FORMUL 3 MG MG 2+ FORMUL 4 HOH *140(H2 O) HELIX 1 AA1 ARG A 53 VAL A 57 5 5 HELIX 2 AA2 VAL A 76 LEU A 86 1 11 HELIX 3 AA3 ALA A 107 GLY A 118 1 12 HELIX 4 AA4 HIS A 162 ARG A 166 5 5 HELIX 5 AA5 SER A 180 VAL A 185 1 6 HELIX 6 AA6 MET A 194 GLN A 203 1 10 HELIX 7 AA7 ASP A 232 TYR A 247 1 16 HELIX 8 AA8 LEU A 248 GLY A 250 5 3 HELIX 9 AA9 GLY A 263 ASP A 277 1 15 HELIX 10 AB1 ASP A 288 ALA A 292 5 5 SHEET 1 AA1 2 LYS A 3 LEU A 7 0 SHEET 2 AA1 2 LEU A 119 ALA A 125 -1 O GLN A 122 N GLN A 4 SHEET 1 AA2 5 ILE A 11 VAL A 16 0 SHEET 2 AA2 5 LYS A 23 PRO A 30 -1 O LEU A 26 N ALA A 13 SHEET 3 AA2 5 ALA A 91 LEU A 95 -1 O GLU A 94 N THR A 27 SHEET 4 AA2 5 ILE A 37 ARG A 41 1 N CYS A 40 O VAL A 93 SHEET 5 AA2 5 VAL A 48 PRO A 51 -1 O ILE A 50 N PHE A 39 SHEET 1 AA3 2 LEU A 66 LYS A 68 0 SHEET 2 AA3 2 VAL A 71 VAL A 73 -1 O VAL A 73 N LEU A 66 SHEET 1 AA4 5 VAL A 135 GLU A 139 0 SHEET 2 AA4 5 LYS A 142 VAL A 147 -1 O PHE A 146 N VAL A 135 SHEET 3 AA4 5 SER A 252 PHE A 260 -1 O PHE A 260 N ARG A 143 SHEET 4 AA4 5 PHE A 152 GLU A 157 1 N SER A 155 O PHE A 257 SHEET 5 AA4 5 GLN A 171 ASP A 175 -1 O VAL A 174 N VAL A 154 SHEET 1 AA5 5 VAL A 135 GLU A 139 0 SHEET 2 AA5 5 LYS A 142 VAL A 147 -1 O PHE A 146 N VAL A 135 SHEET 3 AA5 5 SER A 252 PHE A 260 -1 O PHE A 260 N ARG A 143 SHEET 4 AA5 5 PHE A 128 ILE A 131 1 N VAL A 129 O SER A 252 SHEET 5 AA5 5 TRP A 281 VAL A 284 -1 O GLU A 282 N ARG A 130 SHEET 1 AA6 2 PHE A 191 PHE A 193 0 SHEET 2 AA6 2 ILE A 215 VAL A 217 1 O VAL A 217 N GLY A 192 LINK OD1 ASP A 241 MG MG A 302 1555 1555 2.08 LINK OD2 ASP A 241 MG MG A 302 1555 1555 2.35 LINK O22 JWP A 301 MG MG A 302 1555 1555 2.04 LINK O24 JWP A 301 MG MG A 302 1555 1555 2.18 CISPEP 1 ASP A 45 PRO A 46 0 0.55 SITE 1 AC1 20 HIS A 19 MET A 62 GLU A 77 HIS A 78 SITE 2 AC1 20 THR A 190 PHE A 191 GLY A 192 PHE A 193 SITE 3 AC1 20 ASP A 196 ILE A 197 ALA A 206 GLY A 209 SITE 4 AC1 20 SER A 210 HIS A 237 ASP A 241 HIS A 264 SITE 5 AC1 20 MG A 302 HOH A 408 HOH A 452 HOH A 476 SITE 1 AC2 4 HIS A 78 HIS A 237 ASP A 241 JWP A 301 CRYST1 36.101 66.486 63.565 90.00 90.59 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.027700 0.000000 0.000286 0.00000 SCALE2 0.000000 0.015041 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015733 0.00000